Conolidine’s analgesic effects stem from its interaction with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors inside the central nervous process, conolidine modulates alternate molecular targets. A Science Developments research observed that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, which r